649 related articles for article (PubMed ID: 25088904)
1. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
[TBL] [Abstract][Full Text] [Related]
2. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
3. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
Ghisi V; Ramsey AJ; Masri B; Gainetdinov RR; Caron MG; Salahpour A
Cell Signal; 2009 Jan; 21(1):87-94. PubMed ID: 18929645
[TBL] [Abstract][Full Text] [Related]
4. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
Sammut S; Bray KE; West AR
Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
[TBL] [Abstract][Full Text] [Related]
7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
8. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
9. Evidence of increased dopamine receptor signaling in food-restricted rats.
Carr KD; Tsimberg Y; Berman Y; Yamamoto N
Neuroscience; 2003; 119(4):1157-67. PubMed ID: 12831870
[TBL] [Abstract][Full Text] [Related]
10. The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
Logue SF; Grauer SM; Paulsen J; Graf R; Taylor N; Sung MA; Zhang L; Hughes Z; Pulito VL; Liu F; Rosenzweig-Lipson S; Brandon NJ; Marquis KL; Bates B; Pausch M
Mol Cell Neurosci; 2009 Dec; 42(4):438-47. PubMed ID: 19796684
[TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
12. Reduced basal and ethanol stimulation of striatal extracellular dopamine concentrations in dopamine D2 receptor knockout mice.
Job MO; Ramachandra V; Anders S; Low MJ; Gonzales RA
Synapse; 2006 Aug; 60(2):158-64. PubMed ID: 16715495
[TBL] [Abstract][Full Text] [Related]
13. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
Lindgren N; Usiello A; Goiny M; Haycock J; Erbs E; Greengard P; Hokfelt T; Borrelli E; Fisone G
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4305-9. PubMed ID: 12651945
[TBL] [Abstract][Full Text] [Related]
15. Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype.
Fedele E; Fontana G; Munari C; Cossu M; Raiteri M
Eur J Neurosci; 1999 Jul; 11(7):2351-8. PubMed ID: 10383624
[TBL] [Abstract][Full Text] [Related]
16. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol.
Bertran-Gonzalez J; Bosch C; Maroteaux M; Matamales M; Hervé D; Valjent E; Girault JA
J Neurosci; 2008 May; 28(22):5671-85. PubMed ID: 18509028
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol-induced Nur77 expression in striatopallidal neurons is under the control of protein phosphatase 1 regulation by DARPP-32.
Sánchez N; Coura R; Engmann O; Marion-Poll L; Longueville S; Hervé D; Andrés ME; Girault JA
Neuropharmacology; 2014 Apr; 79():559-66. PubMed ID: 24440754
[TBL] [Abstract][Full Text] [Related]
18. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease.
Oeckl P; Hengerer B; Ferger B
Exp Neurol; 2014 Jul; 257():1-9. PubMed ID: 24747358
[TBL] [Abstract][Full Text] [Related]
19. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum.
Gangarossa G; Perroy J; Valjent E
Brain Struct Funct; 2013 Mar; 218(2):405-19. PubMed ID: 22453353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
